JUL 01, 2016 1:07 PM PDT

Stronger Immune Response to Ward Off Tuberculosis

WRITTEN BY: Kara Marker
Autophagy is a natural process that occurs in the body to remove defective proteins, potentially misfolded or aggregated, from the body to make remove for important, intact sources of energy. In search for a new treatment for tuberculosis that bypasses the growing problem of antibiotic resistance, researchers from Linkoping University are thinking of harnessing the power of autophagy, but there are still a few bumps in the road to resolve.
 Credit: Medical News Today
Tuberculosis (TB) is caused by a bacterium, making antibiotics the primary method of treating infections. However, like many other bacteria species, Mycobacterium tuberculosis finds ways to evolve and become resistant to drugs that target its cellular processes. TB most often affects the lungs, but other parts of the body can be attacked as well. Symptoms of TB usually include a bad, persistent cough, chest pain, and coughing up blood and phlegm. Without treatment, TB is deadly.
 
Isoniazid and rifampicin are two common drugs used to treat TB, but many strains of M. tuberculosis are quickly becoming resistant to these two antibiotics. As an alternative, second-line drugs like amikacin and kanamycin can be used to treat TB, unless the strain if extensively drug-resistant (XDR TB). The more resistant M. tuberculosis bacteria become to existing antibiotics, the more toxic and harmful drugs that are effective will become. That is unless, the researchers from Linkoping University can learn to safely use autophagy as a way to kill TB bacteria.
 
The adapted form of autophagy, called stimulated autophagy, can be very dangerous, mainly when a TB patient also has HIV or when the TB infection is in its first stages where the amount of bacterial colonies is low. When used in these instances, stimulated autophagy actually leads to increased multiplication of bacterial colonies within host cells. When stimulated autophagy is approved to be used, it usually exists in the form of inhibiting a mammalian target of rapamycin complex-1 (mTORC1).
 
For now, finding the “sweet spot” of safe stimulated autophagy will work for patients with aggressive TB infections and those without HIV. However, to address the other two groups, scientists will have to pick apart what causes stimulated autophagy to worsen cases of tuberculosis in these patients. “If this is taken into consideration when new medicines are tested, setbacks could be prevented,” said Robert Blomgran, a research fellow in medicinal microbiology at Linkoping University.
 
This study was recently published in the journal Nature Immunology.
 

 
Sources: Linkoping University,  The Journal of Pathology, Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases, Nature Communications
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 12, 2020
Immunology
Is Gluten Becoming More Immunoreactive?
AUG 12, 2020
Is Gluten Becoming More Immunoreactive?
In recent years, the number of people diagnosed with celiac disease has increased drastically, even with many undiagnose ...
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
SEP 06, 2020
Microbiology
Small Changes in Vaccine Molecules Could Make Them More Effective
SEP 06, 2020
Small Changes in Vaccine Molecules Could Make Them More Effective
Effective vaccines have to trigger an immune response, which is intended to create an immune 'memory' of a specific infe ...
SEP 20, 2020
Microbiology
Middle-Aged Adults Might Always be Susceptible to H3N2 Flu
SEP 20, 2020
Middle-Aged Adults Might Always be Susceptible to H3N2 Flu
People born in the late 1960s or 1970s might be perpetually susceptible to the H3N2 influenza virus, according to new re ...
NOV 01, 2020
Cell & Molecular Biology
There's More to Neutrophil Function Than We Knew
NOV 01, 2020
There's More to Neutrophil Function Than We Knew
Neutrophils are an abundant type of white blood cell that circulate in the blood that can provide a general defense aga ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
Loading Comments...